A Meta-Analysis of eHealth Interventions on Ischaemic Heart Disease Health Outcomes.
LDL
eHealth intervention
ischaemic heart disease
meta-analysis
Journal
Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391
Informations de publication
Date de publication:
2023
2023
Historique:
received:
11
03
2022
accepted:
14
11
2022
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
Electronic Health (eHealth) interventions as a secondary prevention tool to empower patients' health in decision-making and behaviour. With the growing body of evidence supporting the use of eHealth interventions, the intention is to conduct a meta-analysis on various health outcomes of eHealth interventions among ischaemic heart disease (IHD) patients. Based on PRISMA guidelines, eligible studies were searched through databases of Web of Science, Scopus, PubMed, EBSCOHost, and SAGE (PROSPERO registration CRD42021290091). Inclusion criteria were English language and randomised controlled trials published between 2011 to 2021 exploring health outcomes that empower IHD patients with eHealth interventions. RevMan 5.4 was utilised for meta-analysis, sensitivity analysis, and risk of bias (RoB) assessment while GRADE software for generating findings of physical health outcomes. Non-physical health outcomes were analysed using SWiM (synthesis without meta-analysis) method. This review included 10 studies, whereby, six studies with 895 participants' data were pooled for physical health outcomes. Overall, the RoB varied significantly across domains, with the majority was low risks, a substantial proportion of high risks and a sizeable proportion of unclear. With GRADE evidence of moderate to high quality, eHealth interventions improved low density lipoprotien (LDL) levels in IHD patients when compared to usual care after 12 months of interventions (SMD -0.26, 95% CI [-0.45, -0.06], I Electronic Health interventions are found effective at lowering LDL cholesterol in long-term but benefits remain inconclusive for other physical and non-physical health outcomes for IHD patients. Integrating sustainable patient empowerment strategies with the advancement of eHealth interventions by utilising appropriate frameworks is recommended for future research.
Sections du résumé
Background
Electronic Health (eHealth) interventions as a secondary prevention tool to empower patients' health in decision-making and behaviour.
Objective
With the growing body of evidence supporting the use of eHealth interventions, the intention is to conduct a meta-analysis on various health outcomes of eHealth interventions among ischaemic heart disease (IHD) patients.
Methods
Based on PRISMA guidelines, eligible studies were searched through databases of Web of Science, Scopus, PubMed, EBSCOHost, and SAGE (PROSPERO registration CRD42021290091). Inclusion criteria were English language and randomised controlled trials published between 2011 to 2021 exploring health outcomes that empower IHD patients with eHealth interventions. RevMan 5.4 was utilised for meta-analysis, sensitivity analysis, and risk of bias (RoB) assessment while GRADE software for generating findings of physical health outcomes. Non-physical health outcomes were analysed using SWiM (synthesis without meta-analysis) method.
Results
This review included 10 studies, whereby, six studies with 895 participants' data were pooled for physical health outcomes. Overall, the RoB varied significantly across domains, with the majority was low risks, a substantial proportion of high risks and a sizeable proportion of unclear. With GRADE evidence of moderate to high quality, eHealth interventions improved low density lipoprotien (LDL) levels in IHD patients when compared to usual care after 12 months of interventions (SMD -0.26, 95% CI [-0.45, -0.06], I
Conclusions
Electronic Health interventions are found effective at lowering LDL cholesterol in long-term but benefits remain inconclusive for other physical and non-physical health outcomes for IHD patients. Integrating sustainable patient empowerment strategies with the advancement of eHealth interventions by utilising appropriate frameworks is recommended for future research.
Identifiants
pubmed: 36936248
doi: 10.5334/gh.1173
pmc: PMC10022534
doi:
Types de publication
Meta-Analysis
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12Informations de copyright
Copyright: © 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors have no competing interests to declare.
Références
Annu Rev Biomed Eng. 2013;15:359-82
pubmed: 23683088
Patient Educ Couns. 2017 Feb;100(2):320-326
pubmed: 27658660
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Am J Cardiol. 2017 Jan 1;119(1):27-34
pubmed: 27788932
J Med Internet Res. 2017 May 24;19(5):e180
pubmed: 28539302
Digit Health. 2019 Dec 16;5:2055207619896153
pubmed: 31897307
J Med Internet Res. 2015 Oct 21;17(10):e237
pubmed: 26490012
J Am Heart Assoc. 2013 Nov 01;2(6):e000568
pubmed: 24185949
Yearb Med Inform. 2016 Nov 10;(1):93-108
pubmed: 27830236
Heart Vessels. 2017 Apr;32(4):408-418
pubmed: 27730298
Cureus. 2020 Jul 23;12(7):e9349
pubmed: 32742886
J Med Internet Res. 2015 Jul 23;17(7):e185
pubmed: 26206311
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Eur J Prev Cardiol. 2020 Nov;27(16):1782-1792
pubmed: 32106713
J Med Internet Res. 2015 Jan 08;17(1):e10
pubmed: 25574815
J Telemed Telecare. 2021 Nov 26;:1357633X211058329
pubmed: 34825839
Am Heart J. 2017 Jun;188:65-72
pubmed: 28577682
Telemed J E Health. 2018 Jun;24(6):397-405
pubmed: 29112484
Am J Prev Med. 2016 Nov;51(5):814-815
pubmed: 27745680
PLoS One. 2018 Dec 20;13(12):e0197671
pubmed: 30571697
J Med Internet Res. 2018 Oct 02;20(10):e10175
pubmed: 30279155
Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8
pubmed: 24622367
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):281-9
pubmed: 19407659
Clin Cardiol. 2021 May;44(5):609-619
pubmed: 33724494
J Med Internet Res. 2018 Nov 19;20(11):e12052
pubmed: 30455167
Psychosom Med. 2020 May;82(4):409-419
pubmed: 32176191
Lancet Digit Health. 2019 Nov;1(7):e363-e374
pubmed: 33323210
Cochrane Database Syst Rev. 2017 Apr 29;4:CD011851
pubmed: 28455948
J Med Syst. 2022 Jan 24;46(2):13
pubmed: 35072816
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
J Am Heart Assoc. 2015 Nov 09;4(11):
pubmed: 26553211
J Cardiovasc Transl Res. 2020 Aug;13(4):659-667
pubmed: 31820334
JMIR Mhealth Uhealth. 2019 Apr 23;7(4):e10755
pubmed: 31012860
Glob Heart. 2015 Jun;10(2):99-110
pubmed: 26213297
Int J Nurs Stud. 2014 Dec;51(12):1557-67
pubmed: 24856854
BMC Cardiovasc Disord. 2016 Sep 05;16(1):170
pubmed: 27596569
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Diabetes Educ. 2016 Aug;42(4):429-43
pubmed: 27194048
J Adv Nurs. 2020 Mar;76(3):754-772
pubmed: 31769527
J Cancer Surviv. 2016 Oct;10(5):883-97
pubmed: 26984534
J Med Internet Res. 2001 Apr-Jun;3(2):E20
pubmed: 11720962
Eur Cardiol. 2020 Feb 26;15:1-9
pubmed: 32180834
Obes Rev. 2021 Oct;22(10):e13295
pubmed: 34159684
J Clin Lipidol. 2016 May-Jun;10(3):472-89
pubmed: 27206934
Prim Care Diabetes. 2016 Aug;10(4):251-8
pubmed: 26653014